Pfizer (PFE) Intends To Sell About 700M Haleon (HLN) Shares

Pfizer Inc. ("Pfizer") (NYSE: PFE) today announces that it intends to sell approximately 700 million ordinary shares ("Ordinary Shares") in Haleon plc ("Haleon") (NYSE: HLN) , representing approximately 7.7% of Haleon's issued share capital (the "Offering", and such Ordinary Shares in the Offering, the "Sale Shares"). This announcement is not and does not constitute an offer to sell and there will be no public offering of the Sale Shares in any jurisdiction. There will be no sale of any Ordinary Shares in the form of American depositary shares in Haleon.

The price per Sale Share will be determined by way of an accelerated bookbuilding process to institutional investors. The bookbuilding period will commence immediately following this announcement and may close at any time on short notice. The completion of the bookbuilding process and the results of the Offering, including the number of Sale Shares to be sold and the price per Sale Share, will be announced as soon as practicable thereafter.

Pfizer will receive all of the net proceeds from the Offering, subject to customary closing conditions. No Ordinary Shares are being sold or issued by Haleon in the Offering, and Haleon will not receive any of the net proceeds from the Offering.

Completion of the Offering is expected to reduce Pfizer's interest in Haleon from approximately 15.0% to approximately 7.3% of Haleon's issued ordinary shares with voting rights.

J.P. Morgan and Morgan Stanley are acting as joint global coordinators and joint bookrunners (the "Joint Global Coordinators"), HSBC, BNP PARIBAS, Mizuho and UBS are acting as joint bookrunners (the "Joint Bookrunners") and BofA Securities, Deutsche Numis, Goldman Sachs International and Loop Capital Markets are acting as co-managers (the "Co-Managers", and together with the Joint Global Coordinators and the Joint Bookrunners, the "Managers") for the Offering.

Pfizer has undertaken to the Managers not to transfer or dispose of any of its remaining equity securities in Haleon for 60 days from the date of settlement of the Offering, subject to certain exceptions and waiver by the Joint Global Coordinators.

You May Also Be Interested In

• U.S. debt tops $40 trillion
• Ocean Power Technologies revises fiscal 2026 results after audit
• Morgan Stanley Upgrades Merck (MRK) to Overweight